Genenta Science (Nasdaq: GNTA) Employee Directory

Q: What is Genenta Science (Nasdaq: GNTA) known for?

Genenta Science (Nasdaq: GNTA) was founded in 2014. Genenta Science (Nasdaq: GNTA) operates in the Biotechnology Research industry.

Biotechnology ResearchMilan, Italy11-50 Employees

Genenta (Nasdaq: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genenta's first in class product candidate is Temferon™, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed a Phase 1 trial for newly diagnosed Glioblastoma Multiforme patients with an unmethylated MGMT gene promoter, which suggests the potential reprogramming of the tumor microenvironment and inhibiting of myeloid induced tolerance, while allowing the induction of T cell responses, potentially breaking immune tolerance. Genenta has initiated in Q4 2024 a Phase 1/2a metastatic Renal Cell Carcinoma study that will also include combination with immune checkpoint inhibitors. Our treatments are designed as one-time monotherapies, but with the additional potential, when used in combination, to significantly enhance the efficacy of other approved therapeutics.

Find Genenta Science (Nasdaq: GNTA) employees' phone numbers or email addresses

Genenta Science (Nasdaq: GNTA) Global Highlights

Europe
18

Italy
18

North America
7

United States Of America
5
Grenada
1
Mexico
1

Africa
1

South Africa
1

Genenta Science (Nasdaq: GNTA)'s Leadership

C. R.
Cmo
Mobile Phone
Email
C. R.
Cmo & Head Of Development
Mobile Phone
Email
C. R.
Chief Medical Officer
Mobile Phone
Email
G. D. N.
Vice President Corporate Development
Mobile Phone
Email
S. M.
Director Of Program Development
Mobile Phone
Email
M. C.
Director Of Regulatory Affairs
Mobile Phone
Email
R. P.
Clinical Project Manager (cell & Gene Therapy Oncology)
Mobile Phone
Email
V. B.
Clinical Project Manager
Mobile Phone
Email

Genenta Science (Nasdaq: GNTA) Employee Metrics

100%

50%

0%

2025

2024

Program & Project Management
Engineering
Arts & Design
Consultant
Finance
Other
Research
Business Development
Accounting
Marketing

Contact profiles from Genenta Science (Nasdaq: GNTA)

Name

Title

Contact Info

Location

Last Update

C. R.
Cmo
Mobile Phone
Email
United StatesNew Jersey
May 27, 2024
C. R.
Cmo & Head Of Development
Mobile Phone
Email
United StatesNew Jersey
May 27, 2024
C. R.
Chief Medical Officer
Mobile Phone
Email
United StatesNew Jersey
May 27, 2024
G. D. N.
Vice President Corporate Development
Mobile Phone
Email
ItalyLombardy
Oct 31, 2025
S. M.
Director Of Program Development
Mobile Phone
Email
ItalyLombardy
May 27, 2024
M. C.
Director Of Regulatory Affairs
Mobile Phone
Email
Italy
Oct 31, 2025
R. P.
Clinical Project Manager (cell & Gene Therapy Oncology)
Mobile Phone
Email
ItalyLombardia
Oct 21, 2024
V. B.
Clinical Project Manager
Mobile Phone
Email
Italy
Oct 31, 2025
C. A.
Clinical Project Manager And Clinical Scientist
Mobile Phone
Email
ItalyLombardy
Oct 31, 2025
L. G.
Senior Accountant
Mobile Phone
Email
ItalyLombardy
Oct 31, 2025

Frequently Asked Questions

What is Genenta Science (Nasdaq: GNTA) known for?

Genenta Science (Nasdaq: GNTA) was founded in 2014 operates in the Biotechnology Research industry. The company's main headquarters is located in Via Olgettina, 58 Milan, 20132 IT. Explore Genenta Science (Nasdaq: GNTA)'s company overview page for more information.

What is Genenta Science (Nasdaq: GNTA)'s most common email format?

Genenta Science (Nasdaq: GNTA) employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Genenta Science (Nasdaq: GNTA) email formats with LeadIQ.

How many employees does Genenta Science (Nasdaq: GNTA) have currently?

Genenta Science (Nasdaq: GNTA) has approximately 25 employees as of October 2025. These team members are located across 3 continents, including EuropeNorth AmericaAfrica.

Who are Genenta Science (Nasdaq: GNTA)'s key employees and leadership?

As of October 2025, Genenta Science (Nasdaq: GNTA)'s key employees include:

Cmo: C. R.
Cmo & Head Of Development: C. R.
Chief Medical Officer: C. R.
Vice President Corporate Development: G. D. N.
Director Of Program Development: S. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking